Economy/Home · Economy

Pepteron Shares Close Up 3.84%... Attention on Whether Rally Will Continue on the 9th Amid 'Blue Wave'

Pepteron closed more than 3% higher in the previous regular session, and attention is focused on whether the upward momentum will continue in the market on Monday, the 9th. This is because expectations for changes in pharmaceutical and biotech policy and concerns over drug price regulations are mixe

Wooil Shim
Staff Reporter
6 min read
Pepteron Shares Close Up 3.84%... Attention on Whether Rally Will Continue on the 9th Amid 'Blue Wave'
CBC News

Pepteron closed more than 3% higher in the previous regular session, and attention is focused on whether the upward momentum will continue in the market on Monday, the 9th. This is because expectations for changes in pharmaceutical and biotech policy and concerns over drug price regulations are mixed following the 'Blue Wave,' in which the Democratic Party secured majorities in both the Senate and the House in the U.S. midterm elections.

Pepteron (087010) closed the previous regular session at 97,300 won, up 3,600 won (3.84%) from the previous trading day. At a separate trading time point, a price of 98,100 won, up 4,400 won (4.70%), was displayed. However, the market and time of this price's transaction could not be verified, so it should be distinguished from the regular session closing price.

What the Blue Wave Leaves for Biotech Stocks The outcome of this U.S. election is a variable that could affect investment sentiment for domestic biotech stocks. While expectations for the Democratic Party's policies to ease medical cost burdens are being highlighted, there is also the possibility that congressional-level oversight of pharmaceutical companies' drug prices and distribution structures will be strengthened.

However, the Democratic Party's control of Congress does not immediately lead to the withdrawal of pharmaceutical tariffs or improved earnings for domestic biotech companies. Therefore, when evaluating Pepteron's stock price, it is necessary to separate overall sector investment sentiment driven by changes in the U.S. political landscape from the progress of individual businesses. Whether follow-up cooperation with Eli Lilly materializes is also a matter to be confirmed.

Observation Points for Monday's Session In Monday's session, the key observation points are whether an early rise at the open is sustained with trading volume, and whether strength in the pharmaceutical and biotech sectors extends to Pepteron. Whether trading continues above the previous regular session closing price of 97,300 won can also serve as a benchmark for assessing the continuation of the rally. However, this does not mean the price has been confirmed as a technical support level.

Conversely, if selling pressure increases after an upward start or investment sentiment in the biotech sector weakens, volatility could grow. It is also difficult to predict Monday's opening price or further gains based solely on the 98,100 won displayed at the separate time point.

Ultimately, Pepteron's stock price on Monday should be assessed by checking both whether policy expectations from the 'Blue Wave' translate into actual buying and whether additional news regarding the company's commercialization efforts emerges. Rather than explaining the rally solely by the election results, an approach that distinguishes sector supply and demand from company-specific performance is needed.

[This article was written with some assistance from AI. It does not recommend buying or selling specific stocks, and investment decisions and responsibilities rest with the investor.]

Wooil Shim
Staff Reporter

CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.